1. Home
  2. PHAR vs CION Comparison

PHAR vs CION Comparison

Compare PHAR & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • CION
  • Stock Information
  • Founded
  • PHAR 1988
  • CION 2011
  • Country
  • PHAR Netherlands
  • CION United States
  • Employees
  • PHAR N/A
  • CION N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • CION Finance/Investors Services
  • Sector
  • PHAR Health Care
  • CION Finance
  • Exchange
  • PHAR Nasdaq
  • CION Nasdaq
  • Market Cap
  • PHAR 618.3M
  • CION 593.9M
  • IPO Year
  • PHAR N/A
  • CION N/A
  • Fundamental
  • Price
  • PHAR $8.74
  • CION $11.52
  • Analyst Decision
  • PHAR Strong Buy
  • CION Hold
  • Analyst Count
  • PHAR 3
  • CION 2
  • Target Price
  • PHAR $27.00
  • CION $12.25
  • AVG Volume (30 Days)
  • PHAR 5.6K
  • CION 227.3K
  • Earning Date
  • PHAR 03-13-2025
  • CION 03-13-2025
  • Dividend Yield
  • PHAR N/A
  • CION 13.17%
  • EPS Growth
  • PHAR N/A
  • CION 50.69
  • EPS
  • PHAR N/A
  • CION 1.48
  • Revenue
  • PHAR $285,745,000.00
  • CION $254,537,000.00
  • Revenue This Year
  • PHAR $20.08
  • CION $1.10
  • Revenue Next Year
  • PHAR $9.22
  • CION N/A
  • P/E Ratio
  • PHAR N/A
  • CION $7.82
  • Revenue Growth
  • PHAR 30.64
  • CION 3.26
  • 52 Week Low
  • PHAR $6.65
  • CION $10.52
  • 52 Week High
  • PHAR $13.20
  • CION $12.69
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 40.05
  • CION 54.34
  • Support Level
  • PHAR $7.95
  • CION $11.49
  • Resistance Level
  • PHAR $9.35
  • CION $11.76
  • Average True Range (ATR)
  • PHAR 0.52
  • CION 0.16
  • MACD
  • PHAR -0.16
  • CION 0.04
  • Stochastic Oscillator
  • PHAR 22.76
  • CION 68.60

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About CION CION Investment Corporation

CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies.

Share on Social Networks: